TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Thursday. The firm set a “hold” rating on the stock.

TherapeuticsMD Stock Performance

Shares of NASDAQ:TXMD traded down $0.04 on Thursday, reaching $0.85. 16,719 shares of the company were exchanged, compared to its average volume of 152,181. TherapeuticsMD has a 1-year low of $0.70 and a 1-year high of $2.44. The company has a 50-day moving average of $0.93 and a 200-day moving average of $1.20.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.